Key View:

• Real GDP growth will accelerate in Mexico in 2018 and 2019, driven by manufacturing and service sector growth.
• In 2019 and 2020, we expect a further uptick in growth, fuelled by growth in the primary sector and increased public spending under the administration of leftist populist Andres Manuel Lopez Obrador (AMLO).
• However

Key View:

• Mexico remains a key medicine market in Latin America.
• Ageing population and a rising chronic disease burden continues to fuel opportunities for drugmakers.
• Weak regulatory environment and cost-containment measures threaten innovative drugmakers.
   

Forecasts:

The value of Mexico's pharmaceutical market reached MXN189.68bn (USD10

Leftist-populist candidate Andres Manuel Lopez Obrador (AMLO) is likely to win Mexico's July presidential election. However, investor fears that he will reverse key economic reforms are likely overblown, and we do not anticipate a major change in Mexico's growth trajectory.

We believe leftist-populist Andres Manuel Lopez Obrador (AMLO) is likely